Seeing Is Believing
Currently out of the existing stock ratings of Jonathan Yong, 47 are a BUY (45.63%), 50 are a HOLD (48.54%), 6 are a SELL (5.83%).
Analyst Jonathan Yong, currently employed at UBS, carries an average stock price target met ratio of 56.86% that have a potential upside of 16.8% achieved within 101 days. Previously, Jonathan Yong worked at CREDIT SUISSE.
Jonathan Yong’s has documented 228 price targets and ratings displayed on 34 stocks. The coverage is on Healthcare, Financial Services, Consumer Defensive sectors.
Most recent stock forecast was given on CLOV, Clover Health Investments Corp at 07-Oct-2024.
Analyst best performing recommendations are on CLOV (CLOVER HEALTH INVESTMENTS CORP).
The best stock recommendation documented was for CLOV (CLOVER HEALTH INVESTMENTS CORP) at 8/9/2022. The price target of $3 was fulfilled within 1 day with a profit of $0.21 (7.53%) receiving and performance score of 75.27.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$13.5
$-1.37 (-9.21%)
$21
15 days ago
(06-Nov-2024)
6/8 (75%)
$-2.34 (-14.77%)
39
Hold
$23
$8.13 (54.67%)
$8.5
1 months 14 days ago
(07-Oct-2024)
5/7 (71.43%)
$4.52 (24.46%)
228
Hold
$21
$6.13 (41.22%)
$16
6 months 12 days ago
(09-May-2024)
5/5 (100%)
$-1.18 (-5.32%)
18
Hold
$7.5
$-7.37 (-49.56%)
$5
1 years 2 months 22 days ago
(30-Aug-2023)
6/7 (85.71%)
$1.15 (18.11%)
341
Hold
$6
$-8.87 (-59.65%)
$8
1 years 9 months 7 days ago
(14-Feb-2023)
2/2 (100%)
$0.43 (7.72%)
35
Which stock is Jonathan Yong is most bullish on?
Which stock is Jonathan Yong is most reserved on?
What Year was the first public recommendation made by Jonathan Yong?